Key result
Dabigatran for AF linked to aggravated depressive symptoms in a patient with minor depression.
Why the study?
Does dabigatran aggravate depressive symptoms in patients with atrial fibrillation and minor depression?
Case Report (n=1)
Does dabigatran aggravate depressive symptoms in patients with atrial fibrillation and minor depression?
Dabigatran may be associated with aggravated depressive symptoms in patients with atrial fibrillation and minor depression, highlighting the need to monitor for drug interactions.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible mood effects with dabigatran in AF with minor depression; leaves open causality and generalizability.
Several studies have reported that depression and anxiety are very common in atrial fibrillation due to impaired quality of life. Dabigatran is an anti-aggregation agent used for the treatment of atrial fibrillation. In terms of drug interactions during treatment with dabigatran, patients suffering from minor depression are reported to be a population at risk. This report is about a 68-year-old man whose depressive symptoms were aggravated after taking dabigatran for atrial fibrillation. The case is discussed in terms of his aggravated depressive symptoms and the interaction between his prescription medications.
No takes yet. Share an insight, caveat, or question.
Eryılmaz et al. (2014) conducted a case report in Atrial fibrillation and minor depression (n=1). Dabigatran was evaluated on Aggravation of depressive symptoms. Dabigatran use for atrial fibrillation was associated with aggravated depressive symptoms in a 68-year-old man, highlighting potential drug interactions in patients with minor depression.
Synapse has enriched 10 related papers. Consider them for comparative context: